Published: 18 October 2018

Summary of recommendations from the out-of-session meeting of the Medicines Assessment Advisory Committee from 29 August to 1 October 2018


Applications for consent to distribute a new medicine under section 20 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2))


Liposomal Doxorubicin SUN, 2 mg/mL concentrate for infusion (TT50-9159) Pharmacy Retailing (NZ) Ltd

Secretary's note - This recommendation has not been published because the applicant withdrew this application on 16 October 2018, following notification of the recommendation